Applying Machine Learning in Liver Disease and Transplantation: A Comprehensive Review

Machine learning (ML) utilizes artificial intelligence to generate predictive models efficiently and more effectively than conventional methods through detection of hidden patterns within large data sets. With this in mind, there are several areas within hepatology where these methods can be applied. In this review, we examine the literature pertaining to machine learning in hepatology and liver transplant medicine. We provide an overview of the strengths and limitations of ML tools and their potential applications to both clinical and molecular data in hepatology. ML has been applied to various types of data in liver disease research, including clinical, demographic, molecular, radiological, and pathological data. We anticipate that use of ML tools to generate predictive algorithms will change the face of clinical practice in hepatology and transplantation. This review will provide readers with the opportunity to learn about the ML tools available and potential applications to questions of interest in hepatology.

[1]  Johannes Gehrke,et al.  Intelligible Models for HealthCare: Predicting Pneumonia Risk and Hospital 30-day Readmission , 2015, KDD.

[2]  Geoffrey E. Hinton,et al.  Schemata and Sequential Thought Processes in PDP Models , 1986 .

[3]  Yuri Khudyakov,et al.  Computational models of liver fibrosis progression for hepatitis C virus chronic infection , 2014, BMC Bioinformatics.

[4]  César Hervás-Martínez,et al.  Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: results from a multicenter Spanish study. , 2014, Journal of hepatology.

[5]  Corinna Cortes,et al.  Support-Vector Networks , 1995, Machine Learning.

[6]  Xiang Liu,et al.  Learning to Diagnose Cirrhosis with Liver Capsule Guided Ultrasound Image Classification , 2017, Sensors.

[7]  H. Shousha,et al.  Data Mining and Machine Learning Algorithms Using IL28B Genotype and Biochemical Markers Best Predicted Advanced Liver Fibrosis in Chronic Hepatitis C. , 2017, Japanese journal of infectious diseases.

[8]  Manal Alghamdi,et al.  Predicting diabetes mellitus using SMOTE and ensemble machine learning approach: The Henry Ford ExercIse Testing (FIT) project , 2017, PloS one.

[9]  Uri Shaham,et al.  DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network , 2016, BMC Medical Research Methodology.

[10]  I. Vlahavas,et al.  Machine Learning and Data Mining Methods in Diabetes Research , 2017, Computational and structural biotechnology journal.

[11]  Runmin Wei,et al.  Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning , 2018, EBioMedicine.

[12]  Ulysses Balis,et al.  Assessing risk of fibrosis progression and liver-related clinical outcomes among patients with both early stage and advanced chronic hepatitis C , 2017, PloS one.

[13]  Cezary Szmigielski,et al.  Transfer learning with deep convolutional neural network for liver steatosis assessment in ultrasound images , 2018, International Journal of Computer Assisted Radiology and Surgery.

[14]  K. Suh,et al.  Prediction of Acute Kidney Injury after Liver Transplantation: Machine Learning Approaches vs. Logistic Regression Model , 2018, Journal of clinical medicine.

[15]  T M Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.

[16]  Zhe Shen,et al.  Application of Machine Learning Techniques for Clinical Predictive Modeling: A Cross-Sectional Study on Nonalcoholic Fatty Liver Disease in China , 2018, BioMed research international.

[17]  Jonathan H. Chen,et al.  Machine Learning and Prediction in Medicine - Beyond the Peak of Inflated Expectations. , 2017, The New England journal of medicine.

[18]  M. Pérez-Ortiz,et al.  Validation of artificial neural networks as a methodology for donor‐recipient matching for liver transplantation , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  Theodora S. Brisimi,et al.  Predicting diabetes-related hospitalizations based on electronic health records , 2018, Statistical methods in medical research.

[20]  Max Welling,et al.  Auto-Encoding Variational Bayes , 2013, ICLR.

[21]  Qinghui Wang,et al.  Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers , 2010, BMC infectious diseases.

[22]  Henry Völzke,et al.  Development, External Validation, and Comparative Assessment of a New Diagnostic Score for Hepatic Steatosis , 2014, The American Journal of Gastroenterology.

[23]  X. Wang,et al.  Cancer‐associated molecular signature in the tissue samples of patients with cirrhosis , 2004, Hepatology.

[24]  Dimitris Bertsimas,et al.  Development and validation of an optimized prediction of mortality for candidates awaiting liver transplantation , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  Sebastian J. Schlecht,et al.  SurvivalNet: Predicting patient survival from diffusion weighted magnetic resonance images using cascaded fully convolutional and 3D Convolutional Neural Networks , 2017, 2017 IEEE 14th International Symposium on Biomedical Imaging (ISBI 2017).

[26]  B. Kasiske,et al.  NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES , 2003 .

[27]  Chieh-Chen Wu,et al.  Applications of Machine Learning in Fatty Live Disease Prediction , 2018, MIE.

[28]  Jasjit S. Suri,et al.  Author Correction to: Extreme Learning Machine Framework for Risk Stratification of Fatty Liver Disease Using Ultrasound Tissue Characterization , 2017, Journal of Medical Systems.

[29]  Bo Wang,et al.  Visualization and analysis of single-cell RNA-seq data by kernel-based similarity learning , 2016, Nature Methods.

[30]  J. Friedman.  Greedy function approximation: A gradient boosting machine. , 2001 .

[31]  Karim Keshavjee,et al.  A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression , 2018, Scientific Reports.

[32]  Dominik Heider,et al.  Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling , 2014, PloS one.

[33]  Joseph Bockhorst,et al.  Automatic classification of white regions in liver biopsies by supervised machine learning. , 2014, Human pathology.

[34]  Dimitris Bertsimas,et al.  Applied Informatics Decision Support Tool for Mortality Predictions in Patients With Cancer. , 2018, JCO clinical cancer informatics.

[35]  Rich Caruana,et al.  InterpretML: A Unified Framework for Machine Learning Interpretability , 2019, ArXiv.

[36]  Ruxandra Stoean,et al.  Evolutionary-driven support vector machines for determining the degree of liver fibrosis in chronic hepatitis C , 2011, Artif. Intell. Medicine.

[37]  César Hervás-Martínez,et al.  Predicting patient survival after liver transplantation using evolutionary multi-objective artificial neural networks , 2013, Artif. Intell. Medicine.

[38]  P. Lytsy,et al.  Adherence to and beliefs in lipid-lowering medical treatments: a structural equation modeling approach including the necessity-concern framework. , 2013, Patient education and counseling.

[39]  Zhuowen Tu,et al.  Similarity network fusion for aggregating data types on a genomic scale , 2014, Nature Methods.

[40]  Mihaela van der Schaar,et al.  GAIN: Missing Data Imputation using Generative Adversarial Nets , 2018, ICML.

[41]  K. Watt,et al.  New‐Onset Diabetes and Preexisting Diabetes Are Associated With Comparable Reduction in Long‐Term Survival After Liver Transplant: A Machine Learning Approach , 2018, Mayo Clinic proceedings.

[42]  Yoshua Bengio,et al.  Gradient-based learning applied to document recognition , 1998, Proc. IEEE.

[43]  Kun He,et al.  Two Classifiers Based on Serum Peptide Pattern for Prediction of HBV-Induced Liver Cirrhosis Using MALDI-TOF MS , 2013, BioMed research international.

[44]  P. Higgins,et al.  Improvement of predictive models of risk of disease progression in chronic hepatitis C by incorporating longitudinal data , 2015, Hepatology.

[45]  Bertram L Kasiske,et al.  New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. , 2003, Transplantation.

[46]  Xiao-Fei Liu,et al.  An MLP Classifier for Prediction of HBV-Induced Liver Cirrhosis Using Routinely Available Clinical Parameters , 2013, Disease markers.

[47]  Ulrike von Luxburg,et al.  A tutorial on spectral clustering , 2007, Stat. Comput..

[48]  Benjamin I. P. Rubinstein,et al.  Machine-Learning Algorithms Predict Graft Failure After Liver Transplantation , 2017, Transplantation.

[49]  T. Naito,et al.  Prediction of Glucose Metabolism Disorder Risk Using a Machine Learning Algorithm: Pilot Study , 2018, JMIR diabetes.

[50]  Ilias Gatos,et al.  A Machine-Learning Algorithm Toward Color Analysis for Chronic Liver Disease Classification, Employing Ultrasound Shear Wave Elastography. , 2017, Ultrasound in medicine & biology.

[51]  Ying Ju,et al.  Predicting Diabetes Mellitus With Machine Learning Techniques , 2018, Front. Genet..

[52]  G. Su,et al.  Machine learning models to predict disease progression among veterans with hepatitis C virus , 2019, PloS one.

[53]  V. Wong,et al.  Laboratory parameter‐based machine learning model for excluding non‐alcoholic fatty liver disease (NAFLD) in the general population , 2017, Alimentary pharmacology & therapeutics.

[54]  Russell Greiner,et al.  A novel learning algorithm to predict individual survival after liver transplantation for primary sclerosing cholangitis , 2018, PloS one.

[55]  Olivia T. Abar,et al.  A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C , 2007, Hepatology.

[56]  Sara Dorri,et al.  A diagnostic model for cirrhosis in patients with non-alcoholic fatty liver disease: an artificial neural network approach , 2014, Medical journal of the Islamic Republic of Iran.

[57]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[58]  Z. Obermeyer,et al.  Predicting the Future - Big Data, Machine Learning, and Clinical Medicine. , 2016, The New England journal of medicine.

[59]  J. Marrero,et al.  Machine Learning Algorithms Outperform Conventional Regression Models in Predicting Development of Hepatocellular Carcinoma , 2013, The American Journal of Gastroenterology.

[60]  Ying Zhang,et al.  Multivariate Time Series Imputation with Generative Adversarial Networks , 2018, NeurIPS.

[61]  G. Gores,et al.  Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine Learning , 2020, Hepatology.

[62]  J. Ji,et al.  Mast Cells Comprise the Major of Interleukin 17-Producing Cells and Predict a Poor Prognosis in Hepatocellular Carcinoma , 2016, Medicine.